Verona Pharma plc (NASDAQ:VRNA) Receives $74.67 Average PT from Analysts
Shares of Verona Pharma plc (NASDAQ:VRNA – Get Free Report) have received an average recommendation of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month […]
Shares of Verona Pharma plc (NASDAQ:VRNA – Get Free Report) have received an average recommendation of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat.com reports. Six analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month […]
